Research Article
Association of Procalcitonin with the Patient’s Infection Characteristics and Prognosis after Hematopoietic Stem Cell Transplantation
Table 1
Patients with positive blood culture results.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as the median value and interquartile range (IQR). ALL: acute lymphoblastic leukemia; AML: acute myeloid leukemia; CML: chronic myelocytic leukemia; MDS: myelodysplastic syndrome; MM: multiple myeloma; MF: myelofibrosis; AA: aplastic anemia; CRP: C-reactive protein; PCT: procalcitonin; AST: aspartate transaminase; ALT: alanine transaminase; LDH: lactate dehydrogenase; ALP: alkaline phosphatase; CK: creatine kinase; BUN: blood urea nitrogen; BNP: brain natriuretic peptide; Hb: hemoglobin; ALB: albumin; CRE: creatinine; GLU: blood glucose. |